ChemPacific
Generated 5/10/2026
Executive Summary
ChemPacific Corp is a US-based chemical manufacturer and service provider founded in 1995, specializing in custom fine chemicals, agrochemicals, and active pharmaceutical ingredients (APIs). The company operates a unique dual-site model with laboratories and production facilities in both the United States and China, combining American management oversight with cost-effective manufacturing capabilities. This structure allows ChemPacific to offer integrated solutions from early-stage discovery through commercial launch, positioning itself as a reliable sourcing and manufacturing partner for complex chemical synthesis. The company serves a diverse client base across pharmaceuticals, agriculture, and specialty chemicals, leveraging its cross-border operational footprint to deliver cost advantages while maintaining quality and regulatory compliance. ChemPacific operates in a competitive landscape dominated by larger contract development and manufacturing organizations (CDMOs) and Asian suppliers. Its differentiation lies in its ability to bridge US and Chinese operations, offering clients a balance of quality management and competitive pricing. The company is privately held, with no disclosed funding rounds or revenue figures, limiting visibility into its financial health. However, its long operating history suggests stability and niche expertise. Growth opportunities may arise from increasing demand for outsourced chemical manufacturing, particularly for complex APIs and agrochemicals. Risks include geopolitical tensions affecting its China operations, pricing pressure from larger competitors, and potential supply chain disruptions. Overall, ChemPacific appears to be a modest but established player in the custom chemical manufacturing space.
Upcoming Catalysts (preview)
- TBDExpansion of US-based manufacturing capacity60% success
- TBDStrategic partnership with a pharmaceutical or agrochemical company40% success
- TBDNew regulatory approval for an internally manufactured API30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)